Bright Minds Biosciences (DRUG) Research & Development (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Research & Development of $9.5 million for Q1 2026, up 134.39% on a QoQ basis from $4.1 million in Q4 2025, and up 432.65% year-over-year from $1.8 million in Q1 2025.
Bright Minds Biosciences (DRUG) Research & Development (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Research & Development history runs 7 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- Quarterly Research & Development rose 432.65% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (up 683.14% YoY) and the FY2025 annual result came in at $8.1 million, up 831.13% from the prior year.
- Research & Development was $9.5 million for Q1 2026 at Bright Minds Biosciences, up from $4.1 million in the prior quarter.
- Across five years, Research & Development topped out at $9.5 million in Q1 2026 and bottomed at -$414373.2 in Q2 2024.
- A 5-year average of $1.9 million and a median of $1.1 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development slumped 152.98% — and 2025, when it surged 2188.44%.
- Bright Minds Biosciences' Research & Development stood at $1.1 million in 2022, then retreated by 16.29% to $900190.9 in 2023, then fell by 16.87% to $748325.8 in 2024, then surged by 442.43% to $4.1 million in 2025, then soared by 134.39% to $9.5 million in 2026.
- Business Quant data shows DRUG's Research & Development at $9.5 million in Q1 2026, $4.1 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | 9.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.51 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 748,325.78 |
| Sep 30, 2024 | 304,990.54 |
| Jun 30, 2024 | -414,373.17 |
| Mar 31, 2024 | 78,055.47 |
| Dec 31, 2023 | 900,190.92 |
| Sep 30, 2023 | 814,045.11 |
| Jun 30, 2023 | 782,185.04 |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 1.95 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 2.96 Mn |
| Dec 31, 2021 | 3.05 Mn |
| Sep 30, 2021 | 1.75 Mn |
| Jun 30, 2021 | 2.20 Mn |